Neonates, particularly premature infants, are prone to anemia of prematurity (AOP). This condition is characterized by a lower-than-normal red blood cell count, leading to reduced oxygen-carrying capacity. Erythropoietin therapy helps to stimulate erythropoiesis, thereby increasing the red blood cell count and improving oxygenation.
